Importantly, we demonstrated herein that the studied novel derivatives may enhance Ku70 acetylation through inhibition of the tNOX–SIRT1 axis, with concurrently increased c-Flip downregulation and provoked apoptosis in oral cancer cells, regardless of p53 functionality. Here, XRCC6 is linked to lip and oral cavity carcinoma.